Matthew J. Carlyle

Matthew Carlyle, CFA, ICD.D has extensive experience in the finance sector, with a focus on the biotechnology and pharmaceutical industries. Matthew is currently the Chief Operating Officer and CFO at adMare BioInnovations, where they have been since 2019. Prior to this, Matthew held the position of Executive Vice-President and CFO at adMare BioInnovations. In 2019, they also served as the Chief Financial Officer at NEOMED Innovation Centre. Matthew's previous experience includes roles as the Chief Financial Officer at The Centre for Drug Research & Development (CDRD) and Chief Financial Officer at Allon Therapeutics Inc. Matthew also served as Partner at NDI Capital Inc. and held executive positions at Viable Healthworks Corp., Neuro Discovery, and ThoughtShare Communications Inc. Matthew's career spans over two decades, showcasing their expertise in financial management and strategic development.

Matthew Carlyle, CFA, ICD.D attended Queen's University. Matthew holds a Chartered Financial Analyst (CFA) certification from the CFA Institute and an Institute of Corporate Directors (ICD.D) certification obtained in 2019.